Finanical Reports

Explore the landscape of Finanical Reports in China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data and insights on Finanical Reports to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

Novartis Raises Full-Year Core Profit Guidance as Q3 Sales Grow 4% – Kisqali Surges 37% to Lead Priority Brands
Company

Novartis Raises Full-Year Core Profit Guidance as Q3 Sales Grow 4% – Kisqali Surges 37% to Lead Priority Brands

Novartis AG (NYSE: NVS) reported third-quarter 2026 results, with net sales of USD 14.52 billion, up 4% year on year (also +4% in constant currencies, "cc"), and core operating income…

China's National Joint Procurement Office Opens Information Change Channel for National VBP Selected Products – MAH Changes, Entrusted Manufacturer Adjustments and Supplementary Selection Now Permitted While Retaining Selected Status

New VBP Announcement Opens MAH Change and Supplementary Selection Channel – Paper Applications Due Before 30 October 2026 in Shanghai

Genentech's Divarasib Beats Standard‑of‑Care KRAS G12C Inhibitors in Pivotal Phase III Krascendo 1 Study – Superior OS and 42 % Lower Risk of Progression or Death in Pretreated KRAS G12C‑Mutant NSCLC

Genentech’s Divarasib Beats Standard‑of‑Care KRAS G12C Inhibitors in Pivotal Phase III Krascendo 1 Study – Superior OS and 42 % Lower Risk of Progression or Death in Pretreated KRAS G12C‑Mutant NSCLC

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
Company

Sanofi’s Q3 Sales Rise 9% on Dupixent and Flu Vaccine

Company

Junshi Biosciences Reports 55% Drop in Q3 Revenues

Company

RemeGen Reports 397.47% YOY Revenue Growth in Q3 2022

Company

Shanghai Pharmaceuticals Reports 12.86% YOY Revenue Growth in Q3 2022

Company

Merck’s Q3 Sales Rise on Key Drug Performances, China Growth

Company

Ping An Life Insurance Reports Q3 Results, Advances Healthcare Strategy

Company

Novartis Q3 Revenues Rise 4% YOY; China Sales Expand Despite COVID Lockdowns

Company

Huadong Medicine Reports 10.4% Revenue Growth in Q3 2022

Show More